Risk of venous thrombosis with hormone-replacement therapy

被引：39

作者：

Vandenbroucke, JP ^{[1
]}

Helmerhorst, FM ^{[1
]}

机构：

[1] LEIDEN UNIV HOSP,DEPT OBSTET GYNAECOL & REPROD MED,NL-2300 RC LEIDEN,NETHERLANDS

来源：

LANCET | 1996年 / 348卷 / 9033期

关键词：

D O I：

10.1016/S0140-6736(05)64918-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：972 / 972

页数：1

共 8 条

[1]

[Anonymous], 1995, LANCET, V346, P1575

[2]

GOLDHABER SZ, 1994, HAEMOSTASIS THROMBOS, V2, P1327

[3] The long-term clinical course of acute deep venous thrombosis [J].

Prandoni, P ;

Lensing, AWA ;

Cogo, A ;

Cuppini, S ;

Villalta, S ;

Carta, M ;

Cattelan, AM ;

Polistena, P ;

Bernardi, E ;

Prins, MH .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (01) :1-+

[4]

SALZMAN EW, 1994, HEMOSTASIS THROMBOSI, P1275

[5] INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION [J].

VANDENBROUCKE, JP ;

KOSTER, T ;

BRIET, E ;

REITSMA, PH ;

BERTINA, RM ;

ROSENDAAL, FR .

LANCET, 1994, 344 (8935) :1453-1457

[6]

VANDENBROUCKE JP, 1996, GYNECOL ENDOCRINOL, V10, P5

[7] PROGESTAGEN SUPPLEMENTATION OF EXOGENOUS ESTROGENS AND RISK OF ENDOMETRIAL CANCER [J].

VOIGT, LF ;

WEISS, NS ;

CHU, J ;

DALING, JR ;

MCKNIGHT, B ;

VANBELLE, G .

LANCET, 1991, 338 (8762) :274-277

[8]

1996, BRIT MED J, V312, P473

← 1 →